Members of the World Trade Organisation (WTO) on Monday held a discussion with stakeholders like civil society, business representatives and academia on extending the TRIPS decision to Covid-19 therapeutics and diagnostics, an official said.
The issue was discussed in the Trade-Related aspects of Intellectual Property Rights (TRIPS) Council meet in an informal thematic session for external stakeholders.